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BilayerOne way to gain information about the fusogenic potential of virus-derived synthetic peptides is to examine
their interfacial properties and subsequently to study them in monolayers and bilayers. Here, we characterize
the physicochemical surface properties of the peptide E1(64–81), whose sequence is AQLVGELGSLYGPLSVSA.
This peptide is derived from the E1 structural protein of GBV-C/HGV which was previously shown to inhibit
leakage of vesicular contents caused by the HIV-1 fusion peptide (HIV-1 FP). Mixed isotherms of E1(64–81)
and HIV-1 FP were obtained and their Brewster angle microscopy (BAM) and atomic force microscopy (AFM)
images showed that the peptide mixture forms a different structure that is not present in the pure peptide
images. Studies with lipid monolayers (1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG)
and 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) (DPPG)) show that both peptides interact with
all the lipids assayed but the effect that HIV-1 FP has on the monolayers is reduced in the presence of E1(64–
81). Moreover, differential scanning calorimetry (DSC) experiments show the capacity of HIV-1 FP to modify
the properties of the bilayer structure and the capacity of E1(64–81) to inhibit thesemodiﬁcations. Our results
indicate that E1(64–81) interacts with HIV-1 FP to form a new structure, and that this may be the cause of the
previously observed inhibition of the activity of HIV-1 FP by E1(64–81).: +34 93 403 59 87.
artín).
ll rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
The independently discovered human viruses GB virus C (GBV-C)
[1] and hepatitis G virus (HGV) [2] are two isolates of the same single-
stranded RNA virus. GBV-C/HGV shows characteristics of a ﬂavivirus-
like genome, closely related to the hepatitis C virus (HCV).
GBV-C/HGV is widely spread as a result of blood transfusions and
sexual transmission. The virus infects lymphocytes, but not hepato-
cytes and there is no conclusive evidence of a causal link between
GBV-C/HGV and either acute or chronic liver disease. Recently, GBV-C/
HGV has been studied in the context of human immunodeﬁciency
virus (HIV) infection and there are reports that co-infection prolonged
survival of patients and therefore is potentially an effective treatment
[3–5].
Based on a co-infection model, GBV-C/HGV may inﬂuence HIV
disease via inhibition of HIV by inducing chemokines, down-
regulating the HIV co-receptor(s), inﬂuencing cytokine proﬁles, or
having other—as yet undeﬁned—effects on the host lymphocytes [4,5].
However, the mechanism responsible for the beneﬁcial effect that theGBV-C/HGV virus has on the course of disease caused by HIV infection
has not yet been identiﬁed.
The envelope proteins (E) of ﬂaviviruses have been described as
class II fusion proteins [6], characterized by putative fusion sequences
known as fusion peptides. The capacity of these fragments for vesicle
fusion and cell lysis seems to correlate with the strong interaction
these peptides have with membranes.
Bearing in mind the potential use of synthetic peptides as antiviral
therapies, our group is currently examining the capacity of GBV-C/
HGV synthetic peptides to interact with and induce fusion in model
membranes [7,8]. The capacity, observed in vitro, to inhibit the leakage
of vesicular contents caused by the HIV-1 fusion peptide (HIV-1 FP)
[9] is the property that allows us to select the sequences of the
envelop protein E1 of GBV-C/HGV in order to study their interaction
with model membranes and with HIV-1 FP.
In this work, an epitope of GBV-C/HGV located in the (64–81) region
of the E1 structural protein is selected as a possible inhibitor of the
activity of HIV-1 FP. This epitope has also been demonstrated not to be
cytotoxic in vivo and is therefore an interesting sequence to study. The
aim of this work is to study the effect of the E1(64–81) peptide on the
activity of the peptide sequence that represents the 23 N-terminal
residues of the surface protein gp41 of HIV which corresponds to HIV-1
FP. Both peptide sequences are physicochemically characterized by
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teractions with lipid monolayers of 1,2-dimyiristoyl-sn-glycero-3-
[phospho-rac-(1-glycerol)] (DMPG) and 1,2-dipalmitoyl-sn-glycero-3-
phospho-rac-(1-glycerol) (DPPG) are studied. In addition, Langmuir
monolayers are examined by Brewster angle microscopy (BAM) and
atomic force microscopy (AFM). We also study the capacity of the E1
(64–81) peptide sequence to inhibit the interaction with and
destabilization of membranes induced by the HIV-1 FP glycoprotein.
Moreover, peptide–peptide interactions are characterized by means of
Langmuir monolayers and the thermotropic behavior of DMPG and
DPPG multilamellar vesicles (MLV) is studied by differential scanning
calorimetry (DSC), in the absence and in the presence of E1(64–81) and
HIV-1 FP, in view of the fact that lipid membranes are characterized by
one main phase transition between an ordered gel state and a
disordered liquid-crystalline phase, and that they could be affected by
the interaction of the peptides with the bilayer.
2. Experimental
2.1. Materials
Amino acids and Rink amide resin (Tentagel R RAM, 0.19 meq g−1)
were obtained from Novabiochem (Nottingham, UK). Dimethylforma-
mide (DMF) was purchased from Scharlau (Barcelona, Spain).
Dichloromethane (DCM) and piperidine were purchased from
Fluka (Neu-Ulm, Germany). The washing solvents acetic acid, diethyl
ether, and triﬂuoroacetic acid (TFA) were obtained from Merck
(Poole, UK). N-hydroxybenzotriazole (HOBt) and N,N′-diisopropylcar-
bodiimide (DIPCDI) coupling reagents were obtained from Fluka and
Novabiochem, respectively. The other coupling reagents, O-(7-Azaben-
zotriazole-1-yl)-N, N,N′N′-tetramethyluronium hexaﬂuorophosphate
(HATU) and N,N′-diisopropylethylenamine (DEIA), were obtained
from GenScript Corporation and Fluka, respectively. The scavengers
ethanedithiol (EDT) and triisopropylsilane (TIS) were from Sigma-
Aldrich.
1,2-dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG)
and 1,2-dipalmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) (DPPG)
were purchased from Avanti Polar Lipids. Their purity was more
than 99% and they were used without further puriﬁcation.
Chloroform andmethanol were purchased fromMerck. Water was
double distilled and deionized (MilliQ system, Millipore) (18.2 MΩ
cm, pH 5.8). The buffer in all experiments was HEPES (from Sigma-
Aldrich) 5 mM and NaCl (from Merck) 20 mM, pH 7.4.
2.2. Methods
2.2.1. Peptide synthesis
Synthesis of the peptide E1(64–81), whose primary amino acid
sequence is: AQLVGELGSLYGPLSVSA, was carried out on a Tentagel R
RAM resin (0.19 meq g−1), by a solid phase methodology following
an Fmoc/tBu strategy by means of DIPCD/HOBt activation [10]. For
difﬁcult couplings, HATU and DEIA agents were used. Side protection
was effected by: 2,2,5,7,8-pentamethyl-chroman-6-sulfonyl (Pmc) for
Arg; tert-Butyl (tBu) for Tyr, Ser, Thr and Asp; and t-butyloxycarbonyl
(Boc) for Lys and Trp.
A threefold molar excess of Fmoc-amino acids was used through-
out the synthesis. The stepwise addition of each residue was assessed
by Kaiser's (ninhydrin) test [11] and couplings were repeated when
the test result was positive.
The synthesized peptide was deprotected from the side-chain
groups and cleaved from the resin with a treatment of triﬂuoroacetic
acid (TFA) containing appropriate proportions of the scavengers [12]
H2O, triisopropylsilane (TIS), and ethanedithiol (EDT): 94.0% TFA;
2.5% H2O; 2.5% EDT; 1% TIS.
The peptide was characterized by Perkin Elmer analytical HPLC
with an LC-235 Diode Array Detector and a Binary LC Pump 250; thecolumn used was a 25×0.46-cm KROMASIL 100 C18 5 μm. The analysis
was carried out using a linear gradient of 95% H2O (0.05% TFA)/5%
acetonitrile (0.05% TFA) to 5% H2O (0.05% TFA)/95% acetonitrile (0.05%
TFA). Characterization by electrospray mass spectrometry was carried
out by UPLC-MS (Waters ACQUITY Ultra Performance LC™, using a
2.1×100-mm BEH C18 1.7 μm column).
HIV-1 FP/AVGIGALFLGFLGAAGSTMGAAS was synthesized in the
same way but using a ChemMatrix 100% polyethyleneglycol-based
resin.
2.2.2. Surface activity of E1(64–81)
Experimental measurements were recorded with a NIMA Lang-
muir Film Balance equipped with a Wilhelmy platinum plate (NIMA
Technology, Coventry, UK) and a Teﬂon trough that was rinsed with
ethanol and distilled water before use. All experiments were
performed at room temperature.
The surface activity of the peptide was ﬁrst studied to determine
the equilibrium spreading pressure. Using a cylindrical PTFE trough
(19.6 cm2, 27.2 cm3), increasing volumes of 0.28 mMpeptide solution
in acetonitrile/H2O (1:1, v/v) were injected below the HEPES
subphase (pH 7.4) through a lateral hole and the adsorption of the
peptide at the air/water interface was monitored by observing the
increase in surface pressure as a function of time under continuous
stirring of the subphase.
2.2.3. Insertion of peptide into monolayers
The kinetics of insertion of E1(64–81) into monolayers of DMPG
and DPPG were measured using the same trough as for the surface
activity, whichwas cleaned in the samewaywith ethanol and distilled
water before use. For these experiments, a lipid stock solution in
chloroform/methanol (2:1, v/v) was prepared and added dropwise
onto the subphase until the desired lipid pressure was achieved. After
10–20 min, the lipid monolayer reached equilibrium. Then, 0.28 mM
E1(64–81) solution in acetonitrile/H2O (1:1, v/v) was injected into the
subphase through the side hole of the trough. The subphase was
magnetically stirred during the measurements and surface pressure
changes were monitored as a function of time until the pressure
remained constant.
2.2.4. Compression isotherms
Compression isothermswere established in aNIMALangmuir Teﬂon
trough (surface area 595 cm2, volume 297.5 cm3) with two moving
Teﬂon barriers, which was also rinsed with ethanol and distilled water
before use. By depositing appropriate volumes of chloroform/methanol
(2:1, v/v) stock solutions of phospholipids (0.28 mM) and of peptides
(0.28 mM), lipid–peptide spreading solutions were obtained. Mono-
layers were formed by applying small drops of the spreading solutions
onto the HEPES subphase (pH 7.4) with a micro syringe (Hamilton Co.,
Reno, NV, USA). After 15 min, monolayers of the desired composition
were continuously compressed with a rate of area reduction of
15 cm2 min− 1; the area reduction rate ranges from 4.45 to
8.89 Å2 molecule−1 min−1 depending on the volume injected for
each sample necessary to achieve the collapse. The ﬁlms were
compressed to their collapse pressure when possible. Each run was
repeated three times and the reproducibility was ±1 2 molecule−1.
2.2.5. Brewster angle microscopy
BAM images were obtained on a MicroBAM3 instrument (NIMA
Technology) mounted on a NIMA Langmuir balance trough. The
instrument was equipped with a 30-mW laser emitting p-polarized
light at 659 nm, which incises the air–water interface at 53.1°
(Brewster angle). All the images were taken at room temperature.
2.2.6. DSC experiments
Multilamellar lipid vesicles of DMPG and DPPG were prepared for
DSC measurements in a VP-DSC Microcalorimeter (MicroCal LLC,
Fig. 1. Surface activity curve of E1(64–81).
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a chloroform/methanol mixture (2:1, v/v). Mixtures of different lipid
and peptide compositions were prepared and they were evaporated
to dryness in vacuum. Then, the ﬁlms were hydrated with HEPES
buffer (5 mM, pH 7.4) to obtain MLVs [13].
2.2.7. AFM imaging
AFM experiments were performed with a multimode microscope
controlled by Nanoscope IIIa electronics (Digital Instruments, Santa
Barbara, CA, USA). Images were acquired in tapping mode (TM-AFM)
at minimum vertical force, maximizing the amplitude set point value
and maintaining the vibration amplitude as low as possible.
A KSV5000 Langmuir ﬁlm balance with aWilhelmy platinum plate
and a Teﬂon® trough with a surface of 185 cm2 (maximum opened
barriers) and two moving Teﬂon® barriers were used. Deposition of
monolayers was onto a fresh mica substrate (Green Muscovite Mica
disks: Metaﬁx, Montdidier, France) at constant surface pressure for
the AFM study. During the ﬁlm transfer to mica, the surface pressure
was kept constant by the use of a feedback system. Before taking the
measurements, the mica disks were glued onto a steel disk using a
water-insoluble epoxy, and they were then set on the piezoelectric
scanner.
2.2.8. Circular dichroism
Circular dichroism (CD) spectra were recorded on a Jasco J-810
spectropolarimeter (Japan Spectroscopic Company, Tokyo, Japan). All
measurements were taken in water and triﬂuoroethanol (TFE). Cells
1 cm in diameter were used and the spectra were measured between
190 and 260 nm using a spectral bandwidth of 1 nm and a scan speed
of 10 nm/min.
All measurements were performed at 25 °C and the data were
expressed in terms of mean residue ellipticities [θ] (deg cm2 dmol−1).
Three scans were performed to improve the signal to noise ratio. E1
(64–81) was incubated with POPG liposomes before the peptide
spectrum was observed. Finally, a spectrum of the blank solution
(POPG liposomes) was subtracted from the peptide spectrum and the
data converted to mean residue ellipticity units [14]. The Contin
program from the Dichroweb server at http://dichroweb.cryst.bbk.ac.
uk/html/home.shtml was used to treat experimental CD results
[15,16].
3. Results and discussion
3.1. Peptide–peptide interaction
3.1.1. Adsorption kinetic of E1(64–81)
A small gradual adsorption of E1(64–81) was observed at low
peptide concentrations. The higher the peptide concentration in the
subphase, the faster the incorporation process and the higher the
surface pressure attained. Experiments were carried out for more than
an hour in all cases but after 30 min the pressure remained constant
and we considered that at this time equilibrium had been reached.
Fig. 1 shows the adsorption isotherm proﬁle for E1(64–81). The shape
of the surface activity curve approximates a rectangular hyperbola
and it was ﬁtted to Eq. (1) via non-linear least squares regression
analysis.
π=
C π max
K + C
ð1Þ
Where C is the concentration, πmax is the maximum pressure
achieved and K is a characteristic constant equal to the peptide
concentration that yields 12π max. Fitting the data, the values obtained
for E1(64–81) were 17.05 mN m−1 for πmax and 0.20 μM for K
(R2=0.982). Peptide concentrations corresponding to this K value
were chosen for further penetration studies, as it corresponds to theconcentration of the peptide that should be used in the bulk subphase
for penetration kinetics experiments, lower than the equilibrium
spreading pressure of the peptide [17].
By applying the Gibbs adsorption equation in its simple form
(Eq. (2)) it is possible to calculate the peptide surface excess
concentration (Г):
Г =
Δπ
RTΔ lnC
ð2Þ
where R is the gas constant (8.31 J K−1 mol−1), T is the temperature
(298 K), Δπ is the pressure increase achieved 30 min after injection
and C is the peptide concentration.
The surface excess concentration of E1(64–81) at saturation (Гmax)
deduced from the slope of the Δπ− ln C curve (Eq. (2)) was
1.34×10−6 mol m−2. This value allows us to calculate the surface
molecular area by means of Eq. (3), where N is Avogadro's constant.
A =
1
Γmax
N: ð3Þ
The molecular area obtained was 1.24 nm2 molecule−1. This value
is compatible with an α-helical conformation of the peptide and with
vertical orientation at the air–water interface [8,18,19], which was
corroborated by means of CD experiments (Section 3.1.2).
3.1.2. Circular dichroism of E1(64–81)
CD experiments and the corresponding quantitative analysis of the
experimental data using a deconvolution computer program were
performed. In general, short synthetic peptides do not have a
preferential conformation in solution, but they can sometimes adopt
moderately stable secondary structures [20]. The CD experiments
were carried out in the presence of POPG liposomes and the resulting
spectrum is shown in Fig. 2. The negative bands located at 205 and
222 nm and the positive band around 195 nm are characteristic of an
α-helix structure.
3.1.3. Miscibility studies of E1(64–81) and HIV-1 FP
To study the miscibility of the peptides E1(64–81) and HIV-1 FP,
the compression isotherms of each of them and those of their
mixtures were recorded (Fig. 3).
Firstly, studying the E1(64–81) isotherm, we can observe that at
17 mNm−1, when lateral compression takes place [21], the molecular
area was 1.25 nm2 molecule−1 (Fig. 3). This value, obtained from a
dynamic system, is the sameas that obtained fromEq. (3). The value is of
the sameorder as thoseobtainedby other authors for peptidesof similar
amino acid chain length and similar hydrophobic proﬁles based on their
primary sequence; Ambroggio et al. [18] found a molecular area of
1.80 nm2 molecule−1 for citropin, a 16-amino-acid antibiotic peptide.
Moreover, it is similar to themolecular area of anα-helix perpendicular
Fig. 2. CD spectra of E1(64–81) in the presence of POPG liposomes.
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Furthermore, the limiting area (Ao) calculated by extrapolation of the
steep part of the isotherm with the area axis [21], agrees with the
published theoretical values and a plateau can be seen where the
collapse of the monolayer takes place. Ambroggio et al.[18] obtained
1.75 nm2 as the theoretical Ao value for an α-helix peptide oriented
perpendicular to the interface; 1.80 nm2 has been published for an ideal
HIV-1 FP α-helix secondary structure, as calculated by molecular
modeling [23]. In our case, the extrapolated value (1.75 nm2 mole-
cule−1) is greater than the value of 1.25 nm2 found at 17 mNm−1, very
close to the pressure that we postulated as the monolayer collapse
(17.6 mNm−1) based on BAM images recorded at this point. However,
collapse does not disrupt the monolayer but the compressibility does
change at the plateau (see below). This fact allows higher values of
pressure to be achieved in the steep part of the isotherm where the
partial immersion of polar groups of the peptide or folding of the
hydrophobic part are also possible.
From π-A, at low surface pressures (0–10 mNm−1), it can be
observed that the addition of HIV-1 FP to the E1(64–81) monolayer
produces higher values of the mean molecular area as the proportion
increases, indicating interactions between the two peptides. Large
positive deviations observed at E1(64–81) mole fraction values in the
range 0.4≥XE1(64–81)≥0.2, suggest that the E1(64–81)/HIV-1 FP
complex forms clusters in the monolayer.
As can be seen, at a surface pressure of 17 mN m−1, the isotherms
of both peptides present a transition represented by a plateau. This
has been explained in different ways. It is possible that it was the
result of the formation of a bilayer [24] or of the molecular segmentsFig. 3. Surface pressure–mean area per molecule (π-A) compression isotherms of E1
(64–81), HIV-1 FP and their mixtures spread on a HEPES subphase. Inset: plot of
compressibility modulus (Cs−1) as a function of the surface pressure.being lifted from the water surface [25], or of a change in orientation
of the molecules upon compression [26], or it could correspond to a
rearrangement of themolecules as described in the literature for other
peptides with similar characteristics (area per molecule, Ao, and the
absence of clear collapse pressure in compression isotherm register)
[27,28]. The inset in Fig. 3 shows the values of the surface
compressibility modulus (Cs−1) corresponding to each isotherm.
These values were calculated by applying Eq. (4).
C−1s = −A
∂π
∂A
 
T
: ð4Þ
Where A is the area per molecule at the indicated surface pressure
and π is the corresponding surface pressure.
The surface compressibility modulus can be used to characterize
the phase state of the monolayer [29] (for liquid expanded ﬁlms it
ranges from 12.5 to 50 mNm−1, while for the liquid condensed phase
it ranges from 100 to 250 mNm−1) [30].
In our case, the values of Cs−1 indicate that the monolayers are in
the liquid expanded state before and after the transition plateau. The
extension of this plateau decreases as the HIV-1 FP mole fraction
increases, as can be seen in the inset in Fig. 3.
To study what happens, the phase behavior of the E1(64–81)/HIV-
1 FP system was morphologically examined using BAM and AFM.
Figs. 4 and 5 show the BAM and AFM images respectively, corre-
sponding to both peptides separately and to the mixture, where
XE1(64–81)=0.6, at a pressure of 10 mNm−1 when the monolayers are
in the liquid expanded state.
As can be seen in the BAM images, each peptide individually
presents the coexistence of two phases: gas and liquid. However, in
the mixture, we observe a new liquid phase, indicating an interaction
between the peptides. This interaction can also be observed in the
AFM images where the pure peptide LB ﬁlms are quite different from
the LB ﬁlm of the mixture, corroborating that the structure of the
peptides separately is different from that of the mixture at the same
pressure. Firstly, E1(64–81) and HIV-1 FP (Fig. 5a and b) both present
round particles that are ordered differently depending on the peptide.
The E1(64–81) LB ﬁlm (Fig. 5a and d) shows a non-uniform
extension of the peptide on themica surface. The LB ﬁlm presents large
uncovered regions while the monolayer surface had a granular
roughness with small round holes. The monolayer thickness was
determined as the step height from the uncovered mica surface
(the darkest regions in Fig. 5a and d) and the layer, to give a main
height of 1.8±0.2 nm.Meanwhile, for HIV-1 FP, and itsmixturewith E1
(64–81), (Fig. 5b/e and c/f, respectively), the peptide monolayers are
more uniform and themica surface cannot be observed. Furthermore, in
the LBmixed ﬁlm, we can observe curly ﬁlaments of a similar shape and
size covering the surface thatwere not present in the LBﬁlmsof thepure
peptides. This suggests similar peptide behavior to that observed in the
BAM images.
To gain insight into the interactions established between E1(64–81)
and HIV-1 FP, a thermodynamic point of view was considered and the
excess Gibbs energy of mixing (ΔGEXM ) was calculated. The ΔG
EX
M values
provide uswith further information on the energy of themixing process
and the speciﬁc interactions of the two components. Positive values
indicate that the process of mixing is not thermodynamically favorable,
so the mutual interactions between the two components are weaker
than the interactions between the pure component molecules them-
selves. Negative values indicate that the process is thermodynamically
favorable. It must also be noted that when ΔGEXM
 bRT , the differences
from ideality are not considered statistically signiﬁcant and themixture
can be considered ideal [31].
ΔGEXM was calculated using Eq. (5)[32] where NA is Avogadro's
number, A12 is the mean area per molecule in the mixed ﬁlm, A1 and
Fig. 4. 4.1×3.6 mm2 BAM images corresponding to the monolayers of: a) E1(64–81); b)HIV-1 FP; and c) E1(64–81):HIV-1 FP at a molar ratio of 0.6:0.4, spread on HEPES at a surface
pressure of 10 mN m−1.
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fractions, and π is the surface pressure (mN m−1).
ΔGEXM = NA∫
π
π→0
A12dπ−X1∫
π
π→0
A1dπ−X2∫
π
π→0
A2dπ: ð5ÞFig. 5. LB ﬁlms of 2×2 μm (top) and 500×500 nm (bottom) at an extraction surface pressure
FP at a molar ratio of 0.6:0.4.Table 1 shows the ΔGEXM values calculated for the peptide–peptide
mixtures assayed at different surface pressures. In all cases, it can be
seen that ΔGEXM
  values increase with the HIV-1 FP mole fraction. At
surface pressures of 10 mN m−1 or lower and XE1(64–81)≥0.6, the
mixtures have ΔGEXM
 bRT so they can be considered ideal and theof 10 mN m−1: a) and d) E1(64–81); b) and e) HIV-1 FP; and c) and f) E1(64–81):HIV-1
Table 1
GEXM (J mol
−1) for different HIV-1 FP-E1(64–81) mixtures at various pressures.
XE1(64–8l) π (mN m−1) ΔGex (J mol−1)
0.2 5 4494
10 8073
20 23766
25 31990
0.4 5 2146
10 3352
20 8727
25 10980
0.6 5 814
10 1360
20 3861
25 5515
0.8 5 294
10 701
20 3894
25 5909
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component itself are the same. In contrast, for pressures higher than
10 mNm−1 and when the concentration of HIV-1 FP is higher than
the E1(64–81) concentration, ΔGEXM
  values are greater than RT and
positive in all cases.
3.2. Peptide–lipid interactions
The characterization of membrane interactions with peptides or
proteins is important for a better understanding of their mode of
action. In order to determine some peptide–lipid binding properties, a
monolayer approach is used where the peptides are inserted into the
lipid monolayer.
3.2.1. Penetration kinetics
The capacity of the peptide E1(64–81) to penetrate into phospho-
lipid monolayers was studied using a 0.200 μMpeptide solution in the
HEPES-buffered subphase, which corresponds to the K calculated from
Eq. (1). Fig. 6 shows surface pressure increases (Δπ) due to the
introduction of E1(64–81) in monolayers of different phospholipids,
over the initial lipid pressure (πi). For both lipids, the general trend
observed is that the greater the πi, the lower the degree of
incorporation of the peptide into the monolayer because of the closer
packing of the lipids at higher initial pressures.
The monolayer exclusion pressure (that is, the surface pressure
above which the peptide does not penetrate into the monolayer) was
obtained by extrapolating the plot to Δπ=0mNm−1 (Fig. 6) [33].
It can be seen that the peptide interacts with the two lipids tested;
however, a stronger interaction was observed when the monolayer
was composed of DMPG. In this case, the exclusion pressure wasFig. 6. Surface pressure increase (Δπ) caused by E1(64–81) in monolayers of different
phospholipids in front of the initial lipid pressure (πi). Black squares correspond to
DPPG and gray triangles to DMPG.20.06 mN m−1, clearly higher than that obtained when the mono-
layer was of DPPG (11.18 mN m−1). DPPG and DMPG differ in their
hydrocarbonated chains. For DPPG, which presents a higher Cs−1
value, the exclusion pressure is lower than that obtained for DMPG in
a liquid expanded state, which with its lower Cs−1 value is a less rigid
monolayer and, therefore, easier to penetrate than a liquid condensed
monolayer (see at Section 2.2.2 the miscibility study). This corrobo-
rates observations in other studies [28].
3.2.2. Lipid–peptide miscibility
To determine the effect of the peptide E1(64–81) on the state of
phospholipid monolayers and better understand the lipid–peptide
interaction that takes place, mixed monolayers of E1(64–81) and the
two phospholipids were obtained and the compressibility modulus
for all these systems was calculated according to Eq. (4).
Fig. 7 shows the shape of the π-A isotherms obtained and, in the
insets, the variation of the compressibility modulus compared to the
surface pressure.
For both phospholipids, the presence of E1(64–81) results in
higher mean molecular areas of the monolayer than for the pure
phospholipid monolayer at all the molar fractions assayed. For the
DPPG monolayer (Fig. 7a) the π-A isotherm shows a phase transition
at a pressure of around 10 mN m−1 for pure DPPG, which is
signiﬁcantly modiﬁed when E1(64–81) is further incorporated into
the monolayers. This phase transition shows as a minimum in the
compressibility modulus. The same behavior can be observed for
DMPG monolayers, where the phase transition of pure DMPG that
occurs around 30 mNm−1 disappears when E1(64–81) is incorpo-
rated into the monolayer, and a minimum started to appear around
15 mNm−1.Fig. 7. Surface pressure–mean area per molecule (π-A) compression isotherms for E1
(64–81) and the lipids: (a) DPPG and (b) DMPG spread on HEPES subphase (pH=7.4)
at different XE1(64–81). Insets: plots of compressibility modulus (Cs−1) as a function of
the surface pressure.
Fig. 9. Plots of Amolec for E1(64–81) as a function of the peptide molar fractions at
different surface pressures for pure and mixed monolayers of: a) DPPG and b) DMPG.
Dotted lines indicate ideality.
Table 2
GEXM (J mol
−1) for different lipid–E1(64–81) mixtures at various pressures.
ex −1
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of the collapse pressures can be helpful; the variation of πc with the
molar ratio of the components indicates two-dimensional miscibility.
In our case, the collapse pressure of DPPG at 63 mN m−1 barely
change when 20% E1(64–81) is added. However, for DMPG, adding
the same percentage of peptide causes the collapse pressure to
decrease to 55 mN m−1. When the concentration of peptide is
increased, for both phospholipids the collapse pressure decreases.
The variation in the collapse pressure is indicative of miscibility: thus,
in both cases we could see that the peptide and the phospholipids are
miscible, but for DMPG, the earlier variation of the collapse pressure
corroborates the results obtained in the exclusion pressure calculation
where we observed that penetration into DMPG monolayers is easier
than into DPPG monolayers.
To verify the effect of E1(64–81) on the state of phospholipid
monolayers, the maximum compressibility modulus were calculated.
Fig. 8 shows the values in function of peptide concentration. As
indicated above, the incorporation of E1(64–81) into phospholipid
monolayers causes a decrease in the Csmax−1 in all cases, hence, they are
less condensed. This decrease is especially marked for DPPG mono-
layers of XE1(64–81)=0.4. Further additions of the peptide do not affect
the value of Csmax−1 .
Evaluating the extent of intermolecular interactions in monolayers
comprised of two components is aided by the application of the
additivity rule. The additivity rule predicts that, in the case of an ideal
mixture, the mean molecular area (A12) at a given surface pressure
will be equal to the weighted average:
A12 = X1A1 + X2A2 ð7Þ
where A1 and A2 are the molecular areas of the single components at
the same surface pressure and X1 and X2 are the mole fractions of
components 1 and 2 in the mixed ﬁlm. Comparison of the experi-
mental mean molecular area with the expected values from the
additivity rule, provides us with an important clue regarding the
extent of miscibility and interactions in the binary monolayer. The
linear dependence in the area–composition plots (Fig. 9) indicates
ideal mixing or complete immiscibility of the components [34].
Analysis of the plots reveals small negative deviations from
ideality at all XE1(64–81) molar fractions assayed and at different
pressures (5, 10, 15 and 20 mNm−1), suggesting that the peptide
interacts with both phospholipids through attractive interactions
[34,35].
The excess free energy of mixing for the E1(64–81) and DMPG or
DPPG systems was calculated (Table 2).
A positive ΔGEXM reveals that peptide–lipid interactions are less
favorable, while negative values show a more favorable interaction
than between the pure components themselves. In general, the
mixtures have ΔGEXM
 bRT , so they can be considered ideal systems.Fig. 8. Maximum compressibility modulus values in function of peptide concentration
for mixtures with DMPG and DPPG.Fig. 10 shows miniBAM images of monolayers of pure DMPG
(Fig. 10a), pure peptide (Fig. 10c) and a mixed monolayer of DMPG
and the peptide at XE1(64–81)=0.2 (Fig. 10b). The pictures reveal that
at pressures near 15 mN m−1, the monolayer is homogeneous for
pure DMPG and E1(64–81), whereas for the mixture, we can observe
two different phases. This pressure corresponds to the beginning of
the plateau where a change in the compressibility was observed;
therefore we could say that two different phases co-exist in a liquid
expanded state. At a pressure of 17.6 mN m−1, peptide collapse could
be observed (Fig. 10c); while this does not appear in the mixtureXE1(64–8l) ΔG (J mol )
π (mN m−1) DMPG DPPG
0.2 5 −753 −737
10 −780 −791
15 618 486
20 −238 −326
0.4 5 −504 −334
10 −533 −111
15 −470 2188
20 721 590
0.6 5 −133 −257
10 −196 55
15 −523 1687
20 −1694 −630
0.8 5 −317 −248
10 −391 56
15 −491 51
20 −29 −235
Fig. 10. 4.1×3.6 mm2 MiniBAM images of DMPG and E1(64–81) monolayers at three different pressures, and of their mixture: a) DMPG, b) DMPG:E1(64–81) at XE1(64–81)=0.2
and c) E1(64–81).
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other hand, the phase transition observed for DMPG (Fig. 10a, at
π=25.5 mN m−1) is clearly modiﬁed when DMPG is mixed with the
peptide (Fig. 10b, at π=24.6 mN m−1). Moreover, the collapse
observed for the mixture is very different from that of the pure
components, showing a clear phase separation. In previouswork,where
the interaction of E1(145–162) hepatitis G virus peptide and DMPC,
DMPG and POPGwas studied, we reported similar behavior compatible
with the formation of a peptide–lipid complex through hydrophobic
interactions, which was corroborated when the interaction of the same
peptide was studied in a bilayer system [8]. Hence, the higher mean
molecular areas observed in monolayers due to E1(64–81) can be
explained by the formation of the lipid–peptide complexes compatible
with the BAM images and the phase separation observedwhen collapse
is reached. This fact couldbeexplainedby the arrangementof apeptide–
lipid complex and its separation from the lipid matrix.
3.2.3. E1(64–81)-HIV-1 FP–lipid miscibility
Fig. 11a shows the π-A compression isotherms for the HIV-1 FP and
DPPG mixed system. HIV-1 FP addition shifts the isotherm to higher
mean molecular areas at all the molar fractions assayed. Although the
amino acid length is similar to that of E1(64–81), and both peptides
present surface activity with πmax ranging from 17 to 20 mNm−1,
their miscibility pattern is quite different (Figs. 7a and 11a).
To examine the effect of E1(64–81) on the interaction of HIV-1 FP
and phospholipids, mixed monolayers of both peptides and DPPG
were studied. The proportion of E1(64–81):HIV-1 FP was 10:1 as in
this proportion E1(64–81) was found to inhibit the percentage of
leakage caused by HIV-1 FP [9]. Fig. 11b reveals the inhibition effect of
E1(64–81) on the interaction of HIV-1 FP with a DPPGmonolayer. Theshape of the π-A compression isotherms in Fig. 11b is very similar to
that showed in Fig. 7a, corresponding to the E1(64–81)/DPPG mixed
monolayers. Therefore, in the presence of E1(64–81) in vitro, HIV-1 FP
cannot interact with DPPG.
The most signiﬁcant difference can be seen by studying the
compressibility modulus. We observe that the presence of HIV-1 FP
makes the monolayer drastically change from a liquid condensed state
to a liquid expanded state, while with E1(64–81) (Fig. 7a) or with the
mixture of both peptides (Fig. 11b)we observe a transition between the
phaseswhen the peptide concentration is increased. Thus, the presence
of E1(64–81) inhibits the capacity of HIV-1 FP to alter the compress-
ibility of the monolayer.
This inhibition capacity was also studied with DSC experiments
and can be attributed to the new species formed when both
peptides are together, as can be seen in the BAM and AFM images
(Figs. 4 and 5).
On the other hand, Fig. 12 shows the plots of the mean molecular
area calculated fromEq. (7) against the composition. Analysis of Fig. 12a
reveals small negative deviations from ideality at XHIV-1 FP=0.2 and at
different pressures (5, 10, 15 and 20 mNm−1), suggesting that the
peptide interacts with the phospholipid through attractive interactions
[34,35]. However, these deviations become positive at HIV-1 FP molar
ratios higher than 0.2, although they are very small. The deviations
become more positive for X=0.2 and X=0.6 when HIV-1 FP is mixed
with E1(64–81), and more negative for XE1(64–81)+HIV-1 FP=0.4
showing a change in the behavior, but the deviations from ideality are
too small to be considered signiﬁcant.
The excess free energy of mixing for HIV-1 FP and HIV-1 FP+E1
(64–81) with DPPG was calculated (Table 3). All the mixtures have
ΔGEXM
 bRT , so they can be considered ideal systems.
Fig. 11. Surface pressure–mean area per molecule (π-A) compression isotherms for:
(a) HIV-1 FP and DPPG at different XHIV-1 FP and (b) E1(64–81), HIV-1 FP and DPPG at
different XE1(64–81)-HIV-1 FP, spread on HEPES subphase (pH=7.4). Insets: plots of
compressibility modulus (Cs−1) as a function of the surface pressure.
Fig. 12. Plots of Amolec as a function of the peptide molar fractions at different surface
pressures for pure and mixed monolayers of: (a) HIV-1 and DPPG; and (b) HIV-1 FP+
E1(64–81) and DPPG. Dotted lines indicate ideality.
Table 3
GEXM (J mol
−1) for different DPPG–HIV-1 FP mixtures and DPPG–HIV-1 FP+E1(64–81)
mixtures at various pressures.
XPEPTIDE(S) ΔGex (J mol−1)
π (mN m−1) HIV-1 FP:DPPG HIV-1 FP+E1(64–81):DPPG
0.2 5 77 –65
10 −42 121
15 −71 −121
20 −98 −418
0.4 5 11 −2
10 122 196
15 246 −54
20 347 −150
0.6 5 −89 113
10 28 134
15 335 −107
20 475 −601
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To study the modiﬁcations in the phase diagram produced by the
insertion of the peptides into the bilayers, the binary DMPG/DPPG
system was considered. The DMPG/DPPG phase diagram was
constructed from DSC heating thermographs (scans were recorded
between 10 °C and 60 °C) of the liposomes incubated with and
without the peptide. In the heating thermographs (not shown) we
could see how HIV-1 FP modiﬁes the transition temperature (Tm) of
the DPPG and DMPG liposomes, and how this temperature is again
close to the Tm of pure phospholipids when HIV-1 FP is incubatedwith
E1(64–81); this is clearly reﬂected in the phase diagrams.
The heat capacity curve of pure DMPG shows two phase transitions.
The so-called pre-transition (Tp~20.7 °C for DMPG at pH=7.4 in 5 mM
HEPES+20mM NaCl) stands for a transition between two gel phases
(Lβ′→Pβ′). The main phase transition (Tm~23.8 °C) represents the
transition from Pβ′ gel to the liquid crystalline Lα phase. The phase
diagram is constructed considering only themain phase transition [36].
The phase diagram is constructed by the following procedure:
The onset and endset temperatures for the gel to liquid crystalline
phase transition are determined as the temperatures corresponding
to the intersection between the tangent of the leading edge and the
baseline of the DSC curves [36–38]. For their contribution to the total
transition widths, these temperatures need to be as follows [39]:
T1 = Tonset + XAΔT1A + XBΔT1Bð Þ ð8Þ
T2 = Tendset– XAΔT2A + XBΔT2Bð Þ ð9Þwhere,
ΔT1A = Tm–Tonset for XDPPG = 1
ΔT1B = Tm–Tonset for XDPPG = 0
ΔT2A = Tendset–Tm for XDPPG = 1
ΔT2B = Tendset–Tm for XDPPG = 0:
XA and XB correspond to the molar fractions of lipids A (DPPG) and B
(DMPG).
The temperatures calculated by Eqs. (8) and (9) are those
represented in the phase diagram for eachDPPGmolar fraction (Fig. 13).
The shape of a phase diagram depends mainly on the mixing
behavior of the lipids in both phases. For ideal miscibility of two lipids
A and B, the solidus and liquidus curves enclose a cigar-shaped
Fig. 13. Phase diagram of DPPG:DMPG liposomes (solid lines) in the presence of HIV-1
FP (dashed gray lines) and in the presence of HIV-1 FP with E1(64–81) (dotted lines).
G: Gel phase, L: Liquid crystalline phase.
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solidus curve, only the gel phase exists; and above the liquidus line,
only a liquid crystalline phase appears [38]. The phase diagram
conﬁrms ideal mixing of DMPG and DPPG in both phases.
Heat capacity curves were obtained for pure lipids and their
mixtures, as well as for the same phospholipidmixtures with HIV-1 FP
and with HIV-1 FP incubated with E1(64–81), and their phase
diagrams were also constructed.
We observed the capacity of HIV-1 FP to modify the properties of
the bilayer structure, changing the transition temperature, and the
capacity of E1(64–81) to inhibit these modiﬁcations. The resulting
lipid phase diagram is modiﬁed when HIV-1 FP is inserted into the
bilayer. However, no difference is observed in the solidus curve when
HIV-1 FP and E1(64–81) are incubated together. In the liquidus curve,
small differences could be observed but its shape is more similar to
the pure phospholipid curves than to the curve of the phospholipids
incubated HIV-1 FP. The higher XDPPG, the more dramatic the effect is.
4. Conclusions
E1(64–81), a synthetic peptide of the E1 structural protein of GBV-
C/HGV, shows similar behavior to that observed for other peptide
sequences from Hepatitis G structural proteins. E1(64–81) has
moderate surface activity that allows it to adopt an α-helix structure
at the air–water interface. Its interaction with HIV-1 FP was also
studied together with how the presence of E1(64–81) inﬂuences the
interaction of HIV-1 FP with monolayers and bilayers.
In a dynamic system, HIV-1 FP shows an interaction pattern that is
different from that observed for E1(64–81) on phospholipid mono-
layers and bilayers. The interaction of both peptide mixtures with the
same phospholipid systems demonstrated that the presence of E1
(64–81) reduces or inhibits the action of HIV-1 FP. This is observed in
the lipid–peptide miscibility studies as well as in DSC measurements.
Moreover, this in vitro inhibition of the activity of HIV-1 FP could be
explained by the AFM and BAM images which allow us to conclude
that the peptide E1(64–81) interacts with HIV-1 FP to form a new
structure. These ﬁndings could be one more piece of evidence of the
inhibition capacity of the E1(64–81) peptide, as observed in other
assays (ﬂuorescence spectroscopy), corroborating the hypothesis that
synthetic peptides of GBV-C/HGV could inhibit HIV infection. Thus,
our results lead us to propose further study of E1(64–81) to explore
the correlation between its inhibition capacity in vitro and its
biological activity in vivo. We have therefore started the pertinent
studies to establish whether the main trend observed in vitro can be
related with the biological activity in vivo. Furthermore, a more
comprehensive analysis of the speciﬁc peptide–peptide interaction is
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